Inventor · disambiguated record
Mart Saarma
Also filed as: SAARMA MART
22 granted patents·17 pending applications·93 citations·filing 1995–2024
94Inventor score
Top patents by PatentIndex Score
39 records- 0176US7452969B2Neurotrophic factor protein and uses thereofLICENTIA LTD·Filed 2003·Granted Nov 18, 2008·9 cites·2 claims
- 0274US9469679B2Neurturin moleculesNTF THERAPEUTICS INC·Filed 2014·Granted Oct 18, 2016·2 cites·6 claims
- 0374US9127083B2Neurturin moleculesNTF THERAPEUTICS INC·Filed 2013·Granted Sep 8, 2015·2 cites·15 claims
- 0473US9127082B2MANF2 for treatment of Parkinson's diseaseSAARMA MART·Filed 2008·Granted Sep 8, 2015·2 cites·2 claims
- 0573US8853166B2Neurotrophic factor MANF and uses thereofSAARMA MART·Filed 2009·Granted Oct 7, 2014·1 cites·1 claims
- 0671US7786292B2Antisense agents combining strongly bound base-modified oligonucleotide and artificial nucleaseBALTIC TECHNOLOGY DEV LTD·Filed 2007·Granted Aug 31, 2010·3 cites·37 claims
- 0770US8901129B2Methods of facilitating neural cell survival using GDNF family ligand (GFL) mimetics or RET signaling pathway activatorsSAARMA MART·Filed 2010·Granted Dec 2, 2014·3 cites·9 claims
- 0868US9592270B2Neurotrophic factor MANF and uses thereofHERANTIS PHARMA PLC·Filed 2014·Granted Mar 14, 2017·2 cites·6 claims
- 0967US9579362B2Splice variants of GDNF and uses thereofNEVALAITA LIINA·Filed 2008·Granted Feb 28, 2017·2 cites·7 claims
- 1066US6448283B1Methods for preventing/treating damage to sensory hair cells and cochlear neuronsCEPHALON INC·Filed 1999·Granted Sep 10, 2002·29 cites·12 claims
- 1164US8445432B2Neurturin moleculesPENN RICHARD·Filed 2010·Granted May 21, 2013·2 cites·15 claims
- 1263US2020113895A1Method of treating peripheral neuropathyCHEMEDEST LTD·Filed 2019·Application pending·0 cites
- 1362US2025332220A1Use of cerebral dopamine neurotrophic factor for ameliorating pneumoniaNAT DEFENSE MEDICAL CENTER·Filed 2024·Application pending·0 cites
- 1460US8034572B2Receptor for GDNF family ligandsSAARMA MART·Filed 2006·Granted Oct 11, 2011·2 cites·6 claims
- 1560US2021244728A1Method of treating peripheral neuropathyCHEMEDEST LTD·Filed 2021·Application pending·0 cites
- 1656US6696259B1Assays using glial cell line-derived neurotrophic factor receptorsLICENTIA LTD·Filed 1997·Granted Feb 24, 2004·10 cites·2 claims
- 1756US2016136159A1Method for Treating Peripheral NeuropathyCHEMEDEST LTD·Filed 2013·Application pending·0 cites
- 1855US2010285045A1Novel Neurotrophic Factor Protein and Uses ThereofLICENTIA LTD·Filed 2006·Application pending·0 cites
- 1952US8980821B2Treatment with a pharmaceutical composition comprising MANF2 necleic acidSAARMA MART·Filed 2011·Granted Mar 17, 2015·0 cites·3 claims
- 2052US2019153052A1Treatment with a pharmaceutical composition comprising manf2 nucleic acidHERANTIS PHARMA PLC·Filed 2014·Application pending·0 cites
- 2151US2004126819A1Glial cell line-derived neurotrophic factor receptorsFiled 2003·Application pending·0 cites
- 2249US2006195915A1Novel neurotrophic factor protein and uses thereofLICENTIA LTD·Filed 2006·Application pending·0 cites
- 2346US7789610B2Methods for preventing/treating damage to sensory hair cells and cochlear neuronsCEPHALON INC·Filed 2002·Granted Sep 7, 2010·0 cites·22 claims
- 2446US2018036305A1Method of treating peripheral neuropathyCHEMEDEST LTD·Filed 2017·Application pending·0 cites
- 2543US10017553B2Splice variants of GDNF and uses thereofNEVALAITA LIINA·Filed 2017·Granted Jul 10, 2018·0 cites·6 claims
- 2643US5589625ATransgenic plants displaying multiple virus resistance and a process for their productionKEMIRA OY BIOTECH·Filed 1995·Granted Dec 31, 1996·12 cites·24 claims
- 2743US2011171287A1Use of Oligonucleotides with Modified Bases as Antiviral AgentsBALTIC TECHNOLOGY DEVELPMENT LTD·Filed 2008·Application pending·0 cites
- 2840US12479895B2C-terminal CDNF and MANF fragments, pharmaceutical compositions comprising same and uses thereofMYNEUROCURE OY·Filed 2019·Granted Nov 25, 2025·0 cites·8 claims
- 2940US2012171279A1Strongly bound base-modified oligonucleotidesKARELSON MATI·Filed 2010·Application pending·0 cites
- 3039US5882923AGlial cell line-derived neurotrophic factor regulation of ureteric budding and growthFiled 1997·Granted Mar 16, 1999·9 cites·26 claims
- 3138US2011152346A1Use of Oligonucleotides with Modified Bases in Hybridization of Nucleic AcidsBALTIC TECHNOLOGY DEV LTD·Filed 2008·Application pending·0 cites
- 3238US2008070264A1Intracellular Signaling-Induced Ret-Independent Gdnf Receptor-Effected Morphological ChangesJPMORGAN CHASE BANK NA·Filed 2004·Application pending·0 cites
- 3337US2020071372A1C-terminal CDNF and MANF fragments, pharmaceutical compositions comprising same and uses thereofHELSINGIN YLIOPISTO·Filed 2018·Application pending·0 cites
- 3436US7642047B2Method of screening cell death modulatorsARUMAEE URMAS·Filed 2004·Granted Jan 5, 2010·0 cites·11 claims
- 3535US2014259192A1Transgenic animal comprising a deletion or functional deletion of the 3'utr of an endogenous geneSAARMA MART·Filed 2012·Application pending·0 cites
- 3634US7488588B1Compounds related to or derived from GFR α4 and their useLICENTIA LTD·Filed 2000·Granted Feb 10, 2009·0 cites·12 claims
- 3734US2003167520A1Use of a nucleotide sequence for enhancing protein synthesis and expression of proteinsFiled 2001·Application pending·0 cites
- 3824US2019192629A1Compositions Comprising CDNF or MANF for use in the Intranasal Treatment of Central Nervous System DiseasesHERANTIS PHARMA PLC·Filed 2016·Application pending·0 cites
- 3917US6905817B1Ret-independent signaling pathway for GDNFLICESTIA LTD·Filed 1999·Granted Jun 14, 2005·3 cites·91 claims
Join the waitlist — get patent alerts
Get an alert when Mart Saarma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →